← Leaderboards
Jennifer E Klomp
Univ Of North Carolina Chapel Hill
$543,482
Attributed
$543,482
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2019–25$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$543,482 · 3
By mechanism
R00$249,000 · 1
K99$222,876 · 1
F32$71,606 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Jason Marshall Newbern$2,733,962
- Samuel Wayne Jones$784,408
- Lee M Graves$9,136,757
- John Nathaniel Diehl$180,426
- John Elliott Robinson$1,323,153
Others in their field
Other Emerging Leaders on “Mutant”
- Timothy M Willson · University Of Cape Town$12,760,250
- Jacqueline K White · Jackson Laboratory$12,159,072
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$9,169,050
- Kristen A Johnson · California Institute/Biomedical Research$8,530,970
- Frederic Geissmann · Sloan-Kettering Inst Can Research$7,125,954
- John Damon Chodera · Sloan-Kettering Inst Can Research$6,599,276
Research focus
MutantProtein-Serine-Threonine KinasesMalignant Neoplasm Of PancreasMitogen-Activated Protein KinasesOncogenesProteinsIn VitroLibrariesMapk1 GeneMeksMutationCell GrowthPancreatic Ductal AdenocarcinomaPost-Doctoral TrainingCancer CellGrowthAutomobile DrivingKras2 GeneCancer TherapyMalignant NeoplasmsMapk3 GeneCombined Modality TherapyEffective TherapyResearch Clinical Testing
Grant awards (5)
Mechanistic Basis for ERK in driving KRAS-dependent pancreatic cancer$249,000
R00 · FY2025 · CA · contact PI
Mechanistic Basis for ERK in driving KRAS-dependent pancreatic cancer$111,438
K99 · FY2024 · CA · contact PI
Mechanistic Basis for ERK in driving KRAS-dependent pancreatic cancer$111,438
K99 · FY2023 · CA · contact PI
Defining the roles of ERK MAPK in driving KRAS-mutant pancreatic cancer growth.$10,380
F32 · FY2020 · CA · contact PI
Defining the roles of ERK MAPK in driving KRAS-mutant pancreatic cancer growth.$61,226
F32 · FY2019 · CA · contact PI